Separation of anticancer medicines carmustine, lomustine, semustine and melphalan by PAMAM dendrimer: a theoretical study
- 2 Downloads
Much progress has been made in the treatment of cancer. However, it remains a significant challenge to treat as toxic chemotherapeutic drugs are often poorly tolerated when administered together, limiting the patient’s treatment options. A possible solution to this problem is anchoring drugs on the surface of nanoparticles. These systems have a variety of structures with sizes, shapes and materials which determine loading capacity, cellular targeting and stability. Dendrimers are a class of nanoparticles which have been investigated in this context. In this study, we investigated the functionalization of polyamidoamine (PAMAM) dendrimers with some anticancer medications that suppresses the growth of cancer cells (carmustine, lomustine, semustine and melphalan; 1–4). The possibility of drug release, drug delivery and drug separation by PAMAM was theoretically investigated and discussed. The predicted theoretical method will be interesting to remove the pollutants from the medical solutions by PAMAM dendrimer nanoclusters. The results of the modeling were obtained by MMFF94 and RHF/PM6 methods for all form of the PAMAM–medicines complexes. The obtained results by these two methods were shown same trend of the relative energy surfaces of the complexes of PAMAM–medicines 1–4.
KeywordsPolyamidoamine (PAMAM) dendrimers Anticancer medicines Carmustine Lomustine Semustine Melphalan Nanostructures Drug release Drug delivery Drug separation Molecular modeling
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
- 2.B. Klajnert, M. Bryszewska, Dendrimers properties and applications. Acta Bio Chim. Pol. 48(1), 199–208 (2001)Google Scholar
- 10.P.A. Pizzo, D.G. Poplack, Principles and Practice of Pediatric Oncology, 5th edn. (Lippincott Williams & Wilkins, Philadelphia, 2006)Google Scholar
- 12.B. Chabner, D.L. Longo, Cancer Chemotherapy and Biotherapy: Principles and Practice, 4th edn. (Lippincott Willians & Wilkins, Philadelphia, 2005)Google Scholar
- 20.R. Chang, Physical Chemistry for the Biosciences (University Science Books, Sausalito, 2005)Google Scholar
- 21.E.G. Lewars, Computational Chemistry: Introduction to the Theory and Applications of Molecular and Quantum Mechanics (Springer, Berlin, 2010)Google Scholar
- 23.Senn HM, Thiel W, QM/MM methods for biological systems. in Atomistic approaches in modern biology. ed: pp. 173–290, Springer, Berlin (2006)Google Scholar
- 25.D. Young, Computational chemistry: a practical guide for applying techniques to real world problems (John Wiley & Sons Inc, New York, 2004)Google Scholar
- 27.Stewart JJP, Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements, J. Mol. Model. 13(12), 1173–1213 (2007). http://www.semichem.com/ampac/pm6.php. https://en.wikipedia.org/wiki/Semi-empirical_quantum_chemistry_method
- 30.Spatran’10-Quantum Mechanics Program: (PC/x86)-1.1.0v4. 2011, Wavefunction Inc., USAGoogle Scholar
- 31.P. Atkins, J. de Paula, Physical Chemistry, 8th edn. (Oxford University Press, New York, 2006)Google Scholar
- 32.R.G. Mortimer, Physical Chemistry, 3rd edn. (Elsevier Inc., USA, 2008)Google Scholar
- 33.Parimala K, Balachandran V, Vibrational spectroscopic (FTIR and FT Raman) studies, first order hyperpolarizabilities and HOMO, LUMO analysis of p-toluenesulfonyl isocyanate using ab initio HF and DFT methods, Spectrochim. Acta A Mol. Biomol. Spectros 81(1), 711–723 (2011). http://en.wikipedia.org/w/index.php? title = Mulliken_population_analysis&oldid = 572345005